Luo et al. demonstrated that KLF14 can regulate the antioxidant response by regulating the HO-1 pathway in castrate-resistant prostate cancer, thus providing a treatment target for castrate-resistant prostate cancer patients [27]. Here, HMOX1 is linked to prostate carcinoma.